MarketInOut Stock Screener Log In | Sign Up

Maravai LifeSciences Holdings Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Maravai LifeSciences Holdings Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,892.49 mln
Float111 mln
Earnings Date11/04/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.61
Likely reliable

1-Year Forecast

8.50
Modest upside

Relative Strength

95 / 100
Top performer

Debt / Equity

0.86
Moderate leverage

Pre-Tax Margin

-65%
Severely loss-making

Business Description

Maravai LifeSciences Holdings, founded in 2014 and based in San Diego, California, supplies specialized materials and testing tools that help scientists and pharmaceutical companies develop medicines, vaccines, gene therapies, and diagnostic tests across markets worldwide. Through its TriLink division, the company produces the building blocks and chemical tools needed to create and refine DNA and RNA-based treatments, including a proprietary capping technology used in messenger RNA production. Its Cygnus division focuses on quality control, offering testing kits and services that help manufacturers detect and remove unwanted impurities during the production of biological drugs. Together, these two businesses serve a broad range of customers, from large pharmaceutical firms to academic research institutions.

Key Fundamentals

EPS-0.53
ROE-33.95
RPS1.43
ROIC-5.06
ROA-10.09
Interest Cover4.01
EBITDA, mln-55.97
EV / EBITDA-26.48
EV / EBIT-13.17
Revenue, mln209
EV / Revenue7.10

Quote Details

Last 7.81
Change -0.65 (-7.68%)
Open 8.34
Volume 1,703,904
Turnover 13,307,490
Average Volume 2,462,004

Financial Ratios

Pre-Tax Profit Margin-65
Leverage Ratio2.95
Current Ratio4.05
Price / Book6.01
Debt / Equity0.86
Price / Sales5.78

Financial Strength

Altman Z-Score2.93
Piotroski F-Score 5 / 9
Beneish M-Score-2.61
Price to Intrinsic Value0.83
1-Year Target Price8.50
Short Ratio4.94
Short % of Float10.62

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.69% 91 / 100   
1 Month 4.13% 83 / 100   
2 Months 16.74% 91 / 100   
6 Months 109% 99 / 100   
1 Year 154% 99 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog